PHK
ABBV icon

Point72 Hong Kong’s AbbVie ABBV Stock Holding History

Point72 Hong Kong’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,800
Closed -$1.72M – 41
2022
Q3 		$1.72M Sell
12,800
-18,800
-59% -$2.7M 0.06% 397
2022
Q2 		$4.84M Buy
31,600
+6,900
+28% +$1.05M 0.18% 145
2022
Q1 		$4M Buy
24,700
+22,800
+1,200% +$3.31M 0.14% 170
2021
Q4 		$257K Sell
1,900
-11,700
-86% -$1.38M 0.01% 948
2021
Q3 		$1.47M Buy
13,600
+1,700
+14% +$194K 0.05% 588
2021
Q2 		$1.34M Sell
11,900
-23,500
-66% -$2.65M 0.04% 597
2021
Q1 		$3.83M Buy
35,400
+1,400
+4% +$150K 0.13% 188
2020
Q4 		$3.64M Buy
+34,000
New +$3.27M 0.16% 129

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's ABBV Position: Q3 2025 in Review

Point72 Hong Kong sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 120,836 shares — an estimated $22.4M sold.

Point72 Hong Kong first reported a position in ABBV in Q4 2014 and held it in 16 quarters. The position peaked at $22.4M in Q2 2025. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Point72 Hong Kong reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 120,836 AbbVie shares in Q3 2025, an estimated $22.4M.
  • Point72 Hong Kong first reported a position in AbbVie in Q4 2014 and held it in 16 quarters.
  • Point72 Hong Kong's AbbVie position peaked at $22.4M in Q2 2025.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.